National Marfan Foundation - Home
HOME CONTACT
 
Heart and Blood Vessels
Eyes
Skeleton and Joints
Dural Ectasia
Lungs
Dental Issues
Aortic Surgery
Cardiac Emergencies
Eye Emergencies
Lung Emergencies
Pregnancy and Reproduction
Children and Teens
Physical Activity Guidelines
Healthcare Coverage
Patient Protection and Affordable Care Act (PPACA)
SSI/SSDI
Patient Toolkit
Outside the U.S.


Printer Friendly
Aortic Surgery

Dilation of the aortic root is when a segment of the aorta closest to the heart is enlarged.  This is a serious problem and common for people with Marfan syndrome. Surgery is often the treatment when the aortic root gets to be a certain size and emergency surgery is required if the aortic root tears (aortic dissection).

Here are facts about the three different types of surgery commonly practiced for aortic repair. Each type of surgery has advantages and disadvantages. The NMF recommends you use a surgeon who has experience with Marfan aortic root surgery. Talk with your surgeon about which surgery is best for you.

Composite Graft Surgery (Bentall Procedure)
Valve-Sparing Surgery
Bioprosthetic (Tissue) Valve Surgery

Composite Graft Surgery (Bentall Procedure)
In this surgery, the dilated (enlarged) part of aorta and aortic valve are removed. They are replaced with a woven cloth tube that has a mechanical aortic valve sewn to one end. This surgery has been used for more than 30 years. Results last a long time and historically, this has been the most common way to repair the aortic root in people with Marfan syndrome.
 
Advantages of composite graft surgery: 

  • Surgeons have a lot of experience with this type of surgery
  • There are few complications after surgery
  • This repair is very durable, meaning that it usually lasts a person’s lifetime

 Disadvantages of composite graft surgery: 

  • People need to take blood-thinning medication (anticoagulants) for the rest of their lives (and are at risk  of bleeding). 
  • After surgery, people need blood tests (to check blood-thinning medication levels) every week or two. This may happen less often once test results are the same for a while.
  • The mechanical valve is at risk for forming harmful clots and endocarditis (infection of the heart valve).

Valve-Sparing Surgery
In this surgery, the dilated part of the aorta is taken out and replaced with a woven tube The person’s own aortic valve is spared (left in place) and sewn into the end of the tube. This surgery is newer than composite graft surgery.

Advantages of valve-sparing surgery:

  • People do not need to take blood-thinning medication.
  • There is no risk of forming harmful clots and the risk of endocarditis (valve infection) is much less than with a mechanical valve.
  • There are fewer concerns if a woman becomes pregnant after having this surgery.


Disadvantages of valve-sparing surgery:

  • This surgery is a newer procedure and doctors do not yet know how long the repair will last and how long the spared valve will work properly.
  • A person may need more surgery if the aortic valve fails (develops severe leaking).
  • This type of surgery may not be available in all parts of the country. It needs to be done by a surgeon who has had training and experience doing it in people with Marfan syndrome.
  • This surgery is not an option for everyone. Whether a person can have it depends on aorta size, whether there is damage to the aortic valve, and amount of leaking from the aortic valve.  A surgeon’s expertise is very important in this surgery.

Bioprosthetic (Tissue) Valve Surgery
In this type of surgery, the aortic valve is replaced with a bioprosthetic (tissue) valve that has been specially prepared.

Advantages of tissue valve surgery:

  • People do not need to take blood-thinning medication.
  • Surgeons have a lot of experience with this type of surgery.
  • There are several kinds of tissue valves surgeons can chose from.
  • There is no clicking sound from the tissue valve.

 

The NMF is currently funding a research study comparing different types of aortic root surgery.  For more information and eligibility requirements for participation, see Aortic Valve Operative Outcomes in Marfan Patients: A Multi-Center Study under Current Studies.


 

 ENDOVASCULAR STENT-GRAFTING OF THE AORTA  Data on stent-grafts in patients with MFS or other related connective tissue diseases (RCTDs) is very limited.  Therefore, there is insufficient information available to guide decisions regarding its safety and efficacy in these conditions. MFS and RCTDs remain a contraindication for stent-graft repair in all investigational device exemption protocols.  Click here for the NMF Professional Advisory Board Statement on Endovascular Repair in Marfan Syndrome Patients
 
National Marfan Foundation © 2013 • Powered By Big Santo, an Evolving Solutions Product